Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
US6825232B2 · kind B2 · utility
1Cited by
26References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 9, 2003 |
| Grant date | Nov 30, 2004 |
| Priority date | — |
| Expiry date | May 16, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The topical use of HETE compounds to treat ophthalmic inflammatory disorders involving cytokines is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.